Job Role:
The successful candidate will be expected to grow the revenues across all genomic service areas in which we are present, including Next Generation Sequencing, Applied Genomics markets, Sanger sequencing, Oligos, Gene synthesis, Microarray, Genotyping.
The position is home-office based with frequent travel (70%) across the BeNeLux region and to Eurofins Genomics production sites (mostly in Germany).
The Account Manager reports directly to the Country Manager Germany
You’ll be responsible for:
Your profile:
What we offer you:
Do you enjoy being part of a great team and enriching it with your skills? Then apply via the “Apply now!” button, stating your CV and your earliest possible starting date.
Eurofins is an international life science company that provides clients across a range of industries with a unique range of analytical services to make life and our environment safer, healthier and more sustainable. From the food you eat, to the water you drink, to the medicines you rely on, Eurofins works with the world's largest companies to ensure that the products they supply are safe, their ingredients are authentic and the labeling is correct. The company is a leading global provider of analytical services for food, environmental, pharmaceutical and cosmetic products, as well as agricultural contract research organizations (CROs). In addition, Eurofins is one of the independent world market leaders for testing and laboratory services in genomics, pharmacology, forensics, CDMO (contract manufacturing and development), materials science and clinical trial support.
In just 30 years, Eurofins has grown from one laboratory in Nantes, France, to over 58,000 employees in a network of more than 1000 independent companies in over 61 countries with more than 900 laboratories. Eurofins offers a portfolio of more than 200,000 analytical methods to assess the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products as well as innovative clinical diagnostic services as one of the world's leading emerging providers of specialized clinical diagnostic tests.
In 2022, Eurofins generated total revenues of €5.4 billion and has been one of the best performing stocks in Europe over the last 20 years.